| ADR Ontology |
| ADR Term |
Macrophage activation |
| ADR ID |
BADD_A04922 |
| ADR Hierarchy |
|
| Description |
The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. [MeSH] |
| MedDRA Code |
10050206 |
| MeSH ID |
D008262
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Macrophage activation | Macrophage Activation | Activation, Macrophage | Activations, Macrophage | Macrophage Activations |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D00281 | Bleomycin sulfate | - | - |
| The 1th Page 1
Total 1 Pages
|
|
